Patients Living With Gerd Now Have A New Treatment Option For Improved And Sustained Symptom Relief

Friday, Apr. 15th 2011 6:24 AM

Takeda is pleased to announce that DEXILANT™ (dexlansoprazole) is now available in Canada. DEXILANT is the first and only proton pump inhibitor (PPI) with a novel DUAL DELAYED RELEASE technology, which delivers two separate doses of medication at different times providing improved and sustained symptom relief throughout the day and night.

Posted on Friday, Apr. 15th 2011 6:24 AM | by Share of Cost | in Share of Cost | Comments Off on Patients Living With Gerd Now Have A New Treatment Option For Improved And Sustained Symptom Relief